Oral CASE - Pediatrics

335 - Third Party HLA Antibody as a Surrogate Marker for Treatment of Non-HLA AMR

Presentation Number
335
Presenter
Co-Authors

Previous Eposter
432 - Hemodynamic Response to Continuous-flow Left Ventricular Assist Device Ramp Test and Volume Loading Predicts Successful Weaning from the Device Support

Next Eposters
62 - Exosomes With Lung Self-antigens, Kα1Tubulin and Collagen V, as Biomarker for Bronchiolitis Obliterans Syndrome Following Human Lung Transplantation
496 - Distinct Phenotypic, Molecular and Immune Characteristics of Circulating Exosomes From Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome versus Stable Patients
112 - Endothelin-1 Derived from the Pulmonary Endarterectomy Specimen Could Play a Major Role in Pathogenesis of Chronic Thromboembolic Pulmonary Hypertension
64 - Association Between Common Measures of Graft Function and Mortality Post Heart Transplant (HT)
63 - Assessing the Predictive Validity of ISHLT's Primary Graft Dysfunction Classification Instrument
246 - Discontinuing Amiodarone Treatment Prior to Heart Transplant May Lower Incidence of Severe Primary Graft Dysfunction
485 - Outcomes Following Mitraclip in Advanced Heart Failure Patients: A Meta-Analysis
39 - A Comparison of Short Term Outcomes of Minimally Invasive versus Sternotomy Pulmonary Thromboendarterectomy
108 - Variability of Both Raw and Transformed Gene Expression Profile Scores Predict Adverse Events Post Heart Transplant: The Mid America Experience
160 - Discontinuation of Aspirin in Heartmate 3 Left Ventricular Assist Device